Literature DB >> 15888162

Objective assessment of compliance with treatments in acne.

S S Zaghloul1, W J Cunliffe, M J D Goodfield.   

Abstract

BACKGROUND: Acne occurs in prepubertal individuals, teenagers and adults, and can have a devastating effect on self-esteem and social relationships. Whether an acne sufferer will seek treatment often depends, apart from the severity, on cultural and social aspects, which play a significant role in the attitude of the individuals and how they cope with the condition. Compliance with treatment regimen is an essential element in overall effectiveness of therapy.
OBJECTIVES: To assess patient compliance in acne vulgaris.
METHODS: In an open prospective study at a dermatology outpatient clinic, patients with acne, and on isotretinoin or conventional therapies, were examined and completed a questionnaire consisting of: (i) a brief medical and social history, (ii) a compliance assessment sheet, and (iii) the Dermatology Life Quality Index (DLQI). Patients were re-examined after 3 months and their actual treatment usage was directly assessed and compared with expected use. The objective medication adherence (Med Ad) was calculated as (actual treatment use/expected treatment use) x 100. The interview (self-report) Med Ad was obtained by direct questioning. To avoid influencing the behaviour of the subjects, they were not informed of the specific aim of the study: the Local Research Ethics Committee gave approval for this approach. Patient attendance was recorded by referring to the outpatient clinic appointment charts.
RESULTS: Of 687 patients seen who fulfilled the inclusion criteria, 403 completed the study. The mean +/- SD overall objective Med Ad was 64.7 +/- 24% (range 0-111%). The mean +/- SD DLQI was 17.7 +/- 8.1 (range 2-30). There was a highly significant negative correlation (r = -0.87) between DLQI scores and Med Ad. The correlation between age and Med Ad was significantly negative (P < 0.01). Being female, married, employed and not paying for prescriptions were characteristics associated with increased Med Ad and a lower DLQI. Med Ad was greater for isotretinoin therapy and for first time usage of isotretinoin. The major reasons for missing treatment given by the patients were being fed up, forgetful or too busy. Smoking cigarettes and drinking alcohol resulted in reduced Med Ad. The mean +/- SD interview Med Ad was 93.9 +/- 5% (range 85-100%).
CONCLUSIONS: The study demonstrates that a range of disease-related and social factors may influence compliance with treatment in acne. The inverse relationship between DLQI and Med Ad probably reflects the profound interaction of physical and psychological factors as well as perceived treatment failure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15888162     DOI: 10.1111/j.1365-2133.2005.06357.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  15 in total

Review 1.  [Drug therapy of acne].

Authors:  F R Ochsendorf; K Degitz
Journal:  Hautarzt       Date:  2008-07       Impact factor: 0.751

2.  Medication adherence mediates the relationship between marital status and cardiac event-free survival in patients with heart failure.

Authors:  Jia-Rong Wu; Terry A Lennie; Misook L Chung; Susan K Frazier; Rebecca L Dekker; Martha J Biddle; Debra K Moser
Journal:  Heart Lung       Date:  2011-11-03       Impact factor: 2.210

3.  What Health-related Quality of Life Factors Influence the Decision of Patients with Acne to Visit a Dermatologist?

Authors:  Pavel V Chernyshov; Anastasiia Petrenko; Victoria Kopylova
Journal:  J Clin Aesthet Dermatol       Date:  2018-07-01

4.  Sub-group Analyses from a Trial of a Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Gel for the Treatment of Moderate-to-severe Acne Vulgaris.

Authors:  Michael H Gold; Andrew Korotzer
Journal:  J Clin Aesthet Dermatol       Date:  2015-12

5.  Clindamycin 1% Nano-emulsion Gel Formulation for the Treatment of Acne Vulgaris: Results of a Randomized, Active Controlled, Multicentre, Phase IV Clinical Trial.

Authors:  Bhavik Bhavsar; Bimal Choksi; Jayesh Sanmukhani; Alka Dogra; Rizwan Haq; Sudhanshu Mehta; Santanu Mukherjee; V Subramanian; Shafiq Sheikh; Ravindra Mittal
Journal:  J Clin Diagn Res       Date:  2014-08-20

Review 6.  Improving adherence to acne treatment: the emerging role of application software.

Authors:  Chanhyun Park; Gilwan Kim; Isha Patel; Jongwha Chang; Xi Tan
Journal:  Clin Cosmet Investig Dermatol       Date:  2014-02-18

7.  Multicenter study for efficacy and safety evaluation of a fixeddose combination gel with adapalen 0.1% and benzoyl peroxide 2.5% (Epiduo® for the treatment of acne vulgaris in Brazilian population.

Authors:  José Alexandre de Souza Sittart; Adilson da Costa; Fabiane Mulinari-Brenner; Ivonise Follador; Luna Azulay-Abulafia; Lia Cândida Miranda de Castro
Journal:  An Bras Dermatol       Date:  2015-12       Impact factor: 1.896

8.  Ethical considerations in adherence research.

Authors:  Nupur U Patel; Blake A Moore; Rebekah F Craver; Steven R Feldman
Journal:  Patient Prefer Adherence       Date:  2016-12-05       Impact factor: 2.711

9.  Adherence to drug treatments and adjuvant barrier repair therapies are key factors for clinical improvement in mild to moderate acne: the ACTUO observational prospective multicenter cohort trial in 643 patients.

Authors:  Raúl de Lucas; Gerardo Moreno-Arias; Montserrat Perez-López; Ángel Vera-Casaño; Sonia Aladren; Massimo Milani
Journal:  BMC Dermatol       Date:  2015-09-11

10.  Acne subject preference for pump over tube for dispensing fixed-dose combination adapalene 0.1%-benzoyl peroxide 2.5% gel.

Authors:  Maria J Rueda
Journal:  Dermatol Ther (Heidelb)       Date:  2014-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.